KUALA LUMPUR, July 9 -- Biotalys NV, a transformative food and crop protection company has appointed Wim Ottevaere as Chief Financial Officer (CFO), joining the Executive Management Team and will be based in Ghent.
He will provide strategic financial leadership and be focused on supporting the organisation towards its next financing event, according to a statement.
Ottevaere brings more than 40 years of experience in strategic financial roles, raising close to €1billion for multiple biotech companies across various markets. (€1 = RM4.83)
In addition to his new role at Biotalys, Ottevaere will continue to act as non-executive director for several biotech companies.
Prior to joining Biotalys, until September 2018, he was CFO of Ablynx, a leading Belgian biotech company that was listed on Euronext Brussels and Nasdaq until its acquisition by Sanofi in June 2018 for €3.9 billion.
“As we prepare to bring our first biofungicide to market in 2022, Wim Ottevaere completes our executive team and provides the financial expertise Biotalys needs to support our growth,” said Biotalys Chief Executive Officer, Patrice Sellès.
Meanwhile, Ottevaere in a statement said: “Joining Biotalys at this exciting time in its corporate growth journey, I look forward to working with the rest of the executive team to help Biotalys navigate the journey to its next phase as an international commercial player.”
More details at www.biotalys.com.
-- BERNAMA
No comments:
Post a Comment